ISCCA in ESCCA

Opening: J.A. Flores Montero;  M.T. Scupoli

14.40-15.30 1^st session:Rare populations in Hematologic Malignancies setting
Chairs: F. Buccisano ; A. Gatti

Flow Cytometry in CNS disease of Hematologic Malignancies: comparing ESCCA/ISCCA recommendations and survey results
Ilaria Del Principe (ISCCA)

Leukemic Stem Cell as a Biomarker: Flow-Cytometric Insights and Clinical Application – From Bench to Bedside.
Adriana Plesa (ESCCA)

15.30-16.10 2^nd session: Systemic mastocytosis & BCPDN two diseases one marker: CD123
Chairs: J.A. Flores Montero; F. Buccisano

Immunophenotyping of systemic mastocytosis. Clinical and biological significance
Ludovic Lhermitte (ESCCA)

BPDCN: A Diagnostic Challenge
A. Gatti (ISCCA)

16.10-17.20 3^rd session T and NK lymphoproliferative disorders: advances in the diagnosis
Chairs: F. Buccisano; G.Del Zotto

NK-LGLL at the Crossroads of Cytometry and Molecular Biology: Advances in Diagnosis and Characterization
Mikael Roussel ( ESCCA)

Cytometric issues in the diagnosis of T-lymphoproliferative disorders: T-CUS or LGLL?
Valentina Trimarco ( ISCCA)

Closing: J.A -Flores Montero; M.T. Scupoli